Promising drug found to double survival rate for pancreatic cancer The Independent 8d Article paywall
The multi-kinase inhibitor tinengotinib as monotherapy or combined with atezolizumab in advanced solid tumors: a phase Ib/II trial Nature.com 4d
Immune-modulatory cancer vaccine extends PFS in advanced melanoma Dermatology Advisor 16:26 Mon, 04 May
What Krystal Biotech (krys)'s RMAT win for KB707 in lung cancer means for shareholders Simply Wall St 02:59 Mon, 04 May